Article

Carl Zeiss Meditec to acquire Acri.Tec AG

Jena, Germany-Zeiss Meditec hopes to obtain Acri.Tec AG, a leading company in implants for ophthalmic surgery.

Jena, Germany-Carl Zeiss Meditec, a medical technology provider, hopes to obtain Acri.Tec AG, a leading company in implants for ophthalmic surgery. In 2006, Acri.Tec AG's sales totaled €15.4 million in innovative implants and other products for ophthalmic surgery.

The actual purchase price will be determined once it is reduced by net financial debt at the closing date. October 2007 is when the transaction should be completed as long as the German anti-trust authority approves it and contractually agreed conditions have been met.

Ulrich Krauss, president and CEO of Carl Zeiss Meditec, in a prepared statement said Acri.Tec has a name as well recognized as Zeiss and is an important step in the expansion of its product portfolio, especially for innovative IOLs.

Besides devices for diagnosis, treatment and aftercare, the acquisition will also incorporate IOLs for cataract treatments and to correct vision defects. The transaction will also strengthen Carl Zeiss Meditec's business in Germany, according to Krauss.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.